These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26525411)

  • 1. Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
    Christiansen CB; Pallisgaard J; Gerds TA; Olesen JB; Jørgensen ME; Numé AK; Carlson N; Kristensen SL; Gislason G; Torp-Pedersen C
    BMC Neurol; 2015 Nov; 15():225. PubMed ID: 26525411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
    Malloy RJ; Kanaan AO; Silva MA; Donovan JL
    Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Flaherty K; Havard D; Heptinstall S; James M; Krishnan K; Markus HS; Montgomery AA; Pocock SJ; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N;
    Lancet; 2018 Mar; 391(10123):850-859. PubMed ID: 29274727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
    Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW;
    N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
    Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
    Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet Therapy After Noncardioembolic Stroke.
    Greving JP; Diener HC; Reitsma JB; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Algra A
    Stroke; 2019 Jul; 50(7):1812-1818. PubMed ID: 31177983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention with clopidogrel after TIA or stroke].
    Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
    Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
    Hilkens NA; Algra A; Diener HC; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Greving JP
    Stroke; 2021 Oct; 52(10):3258-3265. PubMed ID: 34304604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
    Chaturvedi S
    Clin Ther; 2008 Jul; 30(7):1196-205. PubMed ID: 18691981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ; Eikelboom JW
    Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.
    Geeganage CM; Diener HC; Algra A; Chen C; Topol EJ; Dengler R; Markus HS; Bath MW; Bath PM;
    Stroke; 2012 Apr; 43(4):1058-66. PubMed ID: 22282894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
    Barlas RS; Loke YK; Mamas MA; Bettencourt-Silva JH; Ford I; Clark AB; Bowles KM; Metcalf AK; Potter JF; Myint PK
    Am J Cardiol; 2018 Sep; 122(6):1085-1090. PubMed ID: 30072125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.
    Bath PM; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Heptinstall S; James M; Krishnan K; Markus HS; Pocock S; Ranta A; Robinson TG; Flaherty K; Scutt P; Venables GS; Woodhouse LJ; Sprigg N
    Int J Stroke; 2017 Jul; 12(5):524-538. PubMed ID: 27811309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombotic therapy after cerebral ischemia].
    Schellinger PD; Orberk E; Hacke W
    Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.